Use of Siddha Formulations for SARS-COV2 Variants Infection: A Case Study from India
DOI:
https://doi.org/10.9734/bpi/cpmmr/v7/7186AKeywords:
Sars CoV 2, variants, siddha medicines, maha vasantha kusumakaram tablet, RTPCRAbstract
Many research groups have examined the potential use of natural products and substances already available for use for other indications, such as Ayurvedic formulations that are widely used in India and within the Indian diaspora. Traditional Siddha formulations were given for cases reported with positive Covid 19 infection, in home setting, at Chennai and the reports were shared here. The examples reported here were in close proximity to the potential of omicron and mixed variations, despite the fact that genome sequencing is the precise diagnostic method for variants detection. Thippili rasayanam, adathodai kudineer, and Amukkara choornam are herbal preparations that were shown to work well with Maha vasantha kusumakaram tablet, a shastric higher order metals preparation. The patients recovered in a short span of time and the repeat Real time polymerase chain reaction (RTPCR) tested negative within 10 days. The fact that Siddha medicines were effective against various mutations of the Covid virus without causing any negative side effects was extremely encouraging. Post-testing of liver and kidney parameters further demonstrated the safety and efficacy of the medications. Repurposing already existing drugs in traditional system of medicine for novel diseases like covid19 should be encouraged and time tested in future.